179 related articles for article (PubMed ID: 8289982)
1. Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients.
Phillips AO; Jones HW; Hambley H; Hillis AN; Hendry BM
Nephron; 1993; 65(3):350-3. PubMed ID: 8289982
[TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease.
García-Martín F; De Arriba G; Carrascosa T; Moldenhauer F; Martin-Escobar E; Val J; Saiz F
Nephrol Dial Transplant; 1991; 6(8):543-7. PubMed ID: 1956552
[TBL] [Abstract][Full Text] [Related]
3. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus.
Sitter T; Spannagl M; Schiffl H
Ann Hematol; 1992 Aug; 65(2):79-82. PubMed ID: 1511061
[TBL] [Abstract][Full Text] [Related]
4. Anticardiolipin antibodies: clinical consequences of "low titers".
Silver RM; Porter TF; van Leeuween I; Jeng G; Scott JR; Branch DW
Obstet Gynecol; 1996 Apr; 87(4):494-500. PubMed ID: 8602297
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
6. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
[TBL] [Abstract][Full Text] [Related]
7. Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death.
Al Jameil N; Tyagi P; Al Shenefy A
Int J Clin Exp Pathol; 2015; 8(3):3204-9. PubMed ID: 26045841
[TBL] [Abstract][Full Text] [Related]
8. [Anticardiolipin antibodies in hemodialysis patients and in renal transplant recipients: prevalence and significance].
Ferlazzo B; Barrile A; Bonanno D; Quattrocchi P; Santoro D; Savica V; Bellinghieri G
Recenti Prog Med; 1998 Sep; 89(9):434-7. PubMed ID: 9796372
[TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin antibodies in children on chronic haemodialysis.
Sallam S; Wafa E; el-Gayar A; Sobh M; Salama O
Nephrol Dial Transplant; 1994; 9(9):1292-4. PubMed ID: 7816292
[TBL] [Abstract][Full Text] [Related]
10. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
[TBL] [Abstract][Full Text] [Related]
11. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages.
MacLean MA; Cumming GP; McCall F; Walker ID; Walker JJ
Br J Obstet Gynaecol; 1994 Feb; 101(2):103-6. PubMed ID: 8305382
[TBL] [Abstract][Full Text] [Related]
13. Are antiphospholipid antibodies clinically relevant in dialysis patients?
Chew SL; Lins RL; Daelemans R; Zachee P; De Clerck LS; Vermylen J
Nephrol Dial Transplant; 1992; 7(12):1194-8. PubMed ID: 1337159
[TBL] [Abstract][Full Text] [Related]
14. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
[TBL] [Abstract][Full Text] [Related]
16. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
17. Serum antiphospholipid antibody levels in pseudoexfoliation.
Altintas O; Yuksel N; Sonmez GT; Ozkan B; Altintas L; Caliskan Ş; Caglar Y
J Glaucoma; 2012; 21(5):326-30. PubMed ID: 21423032
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels.
Quintarelli C; Ferro D; Valesini G; Basili S; Tassone G; Violi F
J Hepatol; 1994 Dec; 21(6):1086-91. PubMed ID: 7699232
[TBL] [Abstract][Full Text] [Related]
19. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.
Martinuzzo ME; Pombo G; Forastiero RR; Cerrato GS; Colorio CC; Carreras LO
J Rheumatol; 1998 Jul; 25(7):1313-9. PubMed ID: 9676762
[TBL] [Abstract][Full Text] [Related]
20. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.
Steens SC; Bosma GP; Steup-Beekman GM; le Cessie S; Huizinga TW; van Buchem MA
Arthritis Res Ther; 2006; 8(2):R38. PubMed ID: 16469116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
